Walgreens drops on report that Sycamore potential deal is likely dead
Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...
Drug Store News3d
Walgreens buyout talks reportedly unlikely to culminate in a deal
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
kffhealthnews3d
Walgreens Unlikely To Sell To Private Equity Firm Sycamore Partners
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Becker's Hospital Review3d
Walgreens private equity sale 'mostly dead': Report
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
Crain's Chicago Business3d
Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Nasdaq1mon
Sycamore would likely need partners to take Walgreens private, says Evercore ISI
Evercore ISI notes that The Wall Street Journal reported that Walgreens Boots Alliance (WBA) is in talks with Sycamore Partners to potentially be acquired. The WSJ report suggested Sycamore ...
Walgreens Boots slides after CNBC’s Faber calls Sycamore deal ‘mostly dead’
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
Walgreens Stock Falls on Concerns Potential Buyout Deal is ‘Dead’
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...